Lexicon Pharmaceuticals, Inc. (LXRX) News
Latest headlines that mention LXRX, newest first · each headline opens the original publisher
- Last price
- $1.84
- Day change
- +3.65%
- Next earnings
- —
LXRX headlines
latest coverageNovo Nordisk milestone payment shapes quarter as HCM readout nears.
An analyst at a prominent research firm initiated coverage of the
SONATA-HCM Phase III enrollment topped 500 patients; data due Q1 2027.
One company posts rapid revenue growth but remains unprofitable, while the other boasts global scale and steady cash flow. See how their fundamentals stack up.
Image source: The Motley Fool. Thursday, May 7, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
Also mentioned with LXRX
30d
Headlines that tag both tickers
LXRX news alerts
Get an alert by email or push when a new headline mentions LXRX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.